The nanomedicine revolution: part 2: current and future clinical applications.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

32 citing papers in PubMed.

1. Azithromycin in Dentistry: From Systemic Antibiotic to a Candidate for Local Therapeutic Delivery.Pharmaceutics · 2026
   Review
2. Nanotechnology-Enabled Strategies to Overcome Antibiotic Resistance in Respiratory Infections: Mechanisms, Platforms, and Translational Challenges.Biomedicines · 2026
   Review
3. Nanoparticle Engineering in Modern Vaccinology: From Delivery Platforms to Immune-Programming Architectures.Molecules (Basel, Switzerland) · 2026
   Review
4. Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation.Pharmaceutics · 2026
   Review
5. Nano-engineered leptin mimetics: a precision approach for treating congenital leptin deficiency with hypothalamic dysregulation.Annals of medicine and surgery (2012) · 2026
   Article
6. Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers.Naunyn-Schmiedeberg's archives of pharmacology · 2026
   Review
7. Nanomedicine in the Fight Against Multidrug-Resistant Infections: A Review on Emerging Strategies and Translational Prospects.International journal of nanomedicine · 2025
   Review
8. Emphasis on Nanostructured Lipid Carriers in the Ocular Delivery of Antibiotics.Pharmaceutical nanotechnology · 2024
   Review
9. The direct transfer approach for transcellular drug delivery.Drug delivery · 2023
   Review
10. The Role of Crosslinker Content of Positively Charged NIPAM Nanogels on the In Vivo Toxicity in Zebrafish.Pharmaceutics · 2023
    Article
11. An update on vaccine status and the role of nanomedicine against SARS-CoV-2: A narrative review.Health science reports · 2023
    Article
12. Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future.Pharmaceutics · 2023
    Review
13. Nanomedicine strategies for central nervous system (CNS) diseases.Frontiers in biomaterials science · 2023
    Article
14. Situation analysis on the regulation of nanomedicines in Southern Africa.Frontiers in medicine · 2023
    Article
15. A review and revisit of nanoparticles for antimicrobial drug delivery.Journal of medicine and life · 2022
    Review
16. LongitudinalFrontiers in bioengineering and biotechnology · 2022
    Article
17. Demographic perspectives on the rise of longevity.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
18. Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery.Nanomaterials (Basel, Switzerland) · 2021
    Review
19. Impact of Molybdenum Compounds as Anticancer Agents.Bioinorganic chemistry and applications · 2019
    Review
20. Development and validation of broad-spectrum magnetic particle labelling processes for cell therapy manufacturing.Stem cell research & therapy · 2018
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract